基于类器官构建泛TKI提高ET+CDK4/6抑制剂治疗HR+/HER2-low乳腺癌疗效的筛选工具
吴迎朝,陈柳汕,梁裕琪,陈洁婷,黄俊峰,左谦,陈前军
Development of an organoid⁃based pan⁃TKI precision screening platform to enhance therapeutic efficacy of ET+CDK4/6 inhibitors in HR+/HER2⁃low breast cancer
Yingchao WU,Liushan CHEN,Yuqi LIANG,Jieting CHEN,Junfeng HUANG,Qian ZUO,Qianjun CHEN
实用医学杂志
.
2025, (18): 2786
-2795
.
DOI: 10.3969/j.issn.1006-5725.2025.18.002
